Geron negotiates $50 million at-the-market issuance sales agreement

Offering will be conducted by agent MLV, company reports in 8-K filing

By Devika Patel

Knoxville, Tenn., Oct. 9 - Geron Corp. arranged a $50 million at-the-market issuance sales agreement with MLV & Co. LLC on Oct. 8, according to an 8-K filed Tuesday with the Securities and Exchange Commission.

The sales agreement will terminate upon the earlier of the sale of all common stock under the agreement and Oct. 8, 2015, the filing noted.

Geron, based in Menlo Park, Calif., develops therapeutic treatments for cancer, degenerative diseases and chronic diseases.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.